ICD-10 Coding for Non-Small Cell Lung Cancer(C34.0, C34.1, C34.1M)
Learn about ICD-10 coding for non-small cell lung cancer, including specific codes for different lobes and histologic subtypes.
Complete code families applicable to Non-Small Cell Lung Cancer
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| C34.1 | Malignant neoplasm of upper lobe, bronchus or lung | Use when a malignant neoplasm is confirmed in the upper lobe of the lung. |
|
| M8046/3 | Non-small cell carcinoma, NOS | Use only when no specific subtype can be determined. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutNon-Small Cell Lung Cancer
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Non-Small Cell Lung Cancer.
Documenting 'lung cancer' without specifying type
Impact
Clinical: May lead to inappropriate treatment decisions., Regulatory: Non-compliance with documentation standards., Financial: Potential for denied claims due to lack of specificity.
Mitigation
Educate clinicians on documentation standards, Implement checklist for cancer documentation
Using M8046/3 when a specific subtype is documented
Impact
Reimbursement: May lead to incorrect billing and reimbursement issues., Compliance: Non-compliance with coding guidelines., Data Quality: Decreases accuracy of clinical data.
Mitigation
Always use the specific histology code if available.
Histology specificity
Impact
Risk of audits if NSCLC is coded without specific histology.
Mitigation
Ensure pathology reports are detailed and specific.